Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus

INTRODUCTION: In clinical trials comparing telavancin (TLV) with vancomycin for treatment of hospital-acquired pneumonia, TLV demonstrated lower clinical cure rates than vancomycin in patients who had mixed gram-positive and -negative infections and were concomitantly treated with either aztreonam (...

Descripción completa

Detalles Bibliográficos
Autores principales: Yim, Juwon, Smith, Jordan R., Barber, Katie E., Hallesy, Jessica A., Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019977/
https://www.ncbi.nlm.nih.gov/pubmed/27432414
http://dx.doi.org/10.1007/s40121-016-0121-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019977/
https://www.ncbi.nlm.nih.gov/pubmed/27432414
http://dx.doi.org/10.1007/s40121-016-0121-2

Ejemplares similares